Kiadis Pharma BV, a Dutch oncology drug company, has raised Euro 15 million in new VC funding. Alta Partners led the deal, and was joined by Quest for Growth, MedSciences Capital and return backers Life Sciences Partners, Esprit Capital Partners LLP and N.V. NOM. www.kiadis.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.